Short Decsription
Creative Biolabs offers HEK293T-Tg(Human VPAC2 Receptor) Stable Cell Line which VPAC2 receptor stably expressed in HEK293T cells.
Description
HEK293T-Tg(Human VPAC2 Receptor) Stable Cell Line was engineered to express the receptor human VPAC2 (NM_003382.4). VPAC2 receptor, like VPAC1, is involved in regulating numerous physiological processes in both the CNS and peripheral tissues through its interaction with vasoactive intestinal peptide (VIP). This cell line can be used to study VPAC2 receptor function, signaling pathways, and potential therapeutic interventions.
Features
Minimally modified GPCRs directly selected in functional assays;
Strict quality control;
Parental and orthologous cell lines are available.
Applications
VPAC2 receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
VPAC2
Receptor Family
Vasoactive Intestinal Peptide
Species
Human
Parental Cell Line
HEK293T
Transfection
Full-length Human VIPR2 cDNA (GenBank Accession Number NM_003382.4) with FLAG-tag sequence at N-terminus
Gene
NM_003382.4
Background
VPAC2 receptors are widely distributed in the central nervous system (CNS) and peripheral tissues. In the CNS, they are found in regions such as the cerebral cortex, hippocampus, hypothalamus, and spinal cord. Peripherally, VPAC2 receptors are present in organs like the gastrointestinal tract, pancreas, liver, heart, and immune cells. VPAC2 receptors bind vasoactive intestinal peptide (VIP), a neuropeptide involved in various physiological processes including smooth muscle relaxation, vasodilation, hormone secretion, immune responses, and neurotransmission. Activation of VPAC2 receptors leads to activation of adenylate cyclase and subsequent intracellular signaling pathways, primarily involving cyclic AMP (cAMP) signaling.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.